• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国人群中利用胎儿颈部透明带进行孕早期非整倍体筛查。

First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.

作者信息

Chasen S T, Sharma G, Kalish R B, Chervenak F A

机构信息

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Weill Medical College of Cornell University, New York 10021, USA.

出版信息

Ultrasound Obstet Gynecol. 2003 Aug;22(2):149-51. doi: 10.1002/uog.174.

DOI:10.1002/uog.174
PMID:12905508
Abstract

OBJECTIVE

To examine the detection rate of chromosomal abnormalities using a combination of nuchal translucency (NT) and maternal age in a United States population.

METHODS

A total of 2131 pregnancies with 2339 fetuses underwent NT screening from April 2000 to April 2002 in our ultrasound unit. Nuchal translucency was measured from 11 to 14 weeks' gestation. Fetal crown-rump length (CRL) was also measured. The risk for trisomy 21 was calculated from a combination of maternal age and fetal NT with the use of software provided by The Fetal Medicine Foundation (FMF). Sensitivity and false-positive rates were calculated for different risk cut-offs.

RESULTS

Chromosomal defects were diagnosed in 32 cases, including 12 cases of trisomy 21 and 10 cases of trisomy 18. The estimated risk based on maternal age and fetal NT was 1 in 300 or greater in 195 (8.3%) cases and these included 10/12 (83.3%) pregnancies with trisomy 21 and 9/10 (90.0%) pregnancies with trisomy 18.

CONCLUSION

A combination of maternal age and fetal NT provides an effective method of screening for chromosomal defects. Using ultrasound techniques and risk algorithms from The FMF, the performance of the test in an American population is similar to that described in international populations.

摘要

目的

在美国人群中,研究联合使用颈部透明带(NT)厚度和孕妇年龄检测染色体异常的检出率。

方法

2000年4月至2002年4月,我们超声科对2131例妊娠的2339例胎儿进行了NT筛查。在妊娠11至14周时测量颈部透明带厚度。同时测量胎儿头臀长度(CRL)。使用胎儿医学基金会(FMF)提供的软件,根据孕妇年龄和胎儿NT厚度计算21三体综合征的风险。计算不同风险截断值时的敏感性和假阳性率。

结果

共诊断出32例染色体缺陷,其中12例为21三体综合征,10例为18三体综合征。根据孕妇年龄和胎儿NT厚度估计的风险在195例(8.3%)中为1/300或更高,其中包括10/12(83.3%)例21三体综合征妊娠和9/10(90.0%)例18三体综合征妊娠。

结论

孕妇年龄和胎儿NT厚度联合使用为筛查染色体缺陷提供了一种有效的方法。采用FMF的超声技术和风险算法,该检测方法在美国人群中的表现与国际人群中描述的相似。

相似文献

1
First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population.美国人群中利用胎儿颈部透明带进行孕早期非整倍体筛查。
Ultrasound Obstet Gynecol. 2003 Aug;22(2):149-51. doi: 10.1002/uog.174.
2
First-trimester screening for chromosomal abnormalities by fetal nuchal translucency in a Brazilian population.巴西人群中通过胎儿颈部半透明厚度进行孕早期染色体异常筛查。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):652-5. doi: 10.1046/j.0960-7692.2001.00588.x.
3
Fetal nuchal translucency screening in 12495 pregnancies in Sardinia.撒丁岛12495例妊娠中的胎儿颈部透明带筛查。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):649-51. doi: 10.1046/j.0960-7692.2001.00583.x.
4
Screening for trisomy 21 by fetal nuchal translucency and maternal age: a multicenter project in Germany, Austria and Switzerland.通过胎儿颈部透明带厚度和孕妇年龄筛查21三体综合征:德国、奥地利和瑞士的一项多中心项目。
Ultrasound Obstet Gynecol. 2001 Dec;18(6):645-8. doi: 10.1046/j.0960-7692.2001.00604.x.
5
[Screening for aneuploidy by first trimester nuchal translucency measurement: results from a prospective trial including 1980 cases in a single center in Switzerland].[通过孕早期颈部透明带测量筛查非整倍体:瑞士单一中心1980例前瞻性试验结果]
Ultraschall Med. 2002 Feb;23(1):22-6. doi: 10.1055/s-2002-20076.
6
Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.孕11至14周时通过孕妇年龄、胎儿颈部透明带厚度及孕妇血清生化指标筛查21三体综合征:一项德国多中心研究
J Matern Fetal Neonatal Med. 2002 Aug;12(2):89-94. doi: 10.1080/jmf.12.2.89.94.
7
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.英国多中心项目:通过孕10 - 14周时孕妇年龄和胎儿颈部透明带厚度评估21三体综合征风险。胎儿医学基金会孕早期筛查小组。
Lancet. 1998 Aug 1;352(9125):343-6. doi: 10.1016/s0140-6736(97)11280-6.
8
A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.一项在孕10至14周时利用胎儿颈部透明带、母体血清游离β-人绒毛膜促性腺激素和妊娠相关血浆蛋白A进行21三体综合征筛查的项目。
Ultrasound Obstet Gynecol. 1999 Apr;13(4):231-7. doi: 10.1046/j.1469-0705.1999.13040231.x.
9
Nuchal translucency measurement in first trimester Down syndrome screening.孕早期唐氏综合征筛查中的颈部透明带测量
Issues Emerg Health Technol. 2007 Jun(100):1-6.
10
Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.未选择的妊娠中孕早期颈项透明层筛查时胎儿鼻骨缺失与非整倍体情况
Prenat Diagn. 2003 Jun;23(6):496-500. doi: 10.1002/pd.628.

引用本文的文献

1
Effectiveness of Fetal Medicine Foundation's Non-Biochemical Risk Calculation Algorithm in Detection of Common Trisomies Screening at 11-13 weeks of Gestation: 12 Years' Experience in Northern Thailand.胎儿医学基金会非生化风险计算算法在孕11至13周常见三体筛查中的有效性:泰国北部的12年经验
Int J Womens Health. 2025 Jun 5;17:1693-1699. doi: 10.2147/IJWH.S526271. eCollection 2025.
2
Pregnancy outcomes of 4,200 fetuses with increased nuchal translucency in Henan, China.中国河南4200例颈部透明带增厚胎儿的妊娠结局
Front Med (Lausanne). 2025 Apr 2;12:1514504. doi: 10.3389/fmed.2025.1514504. eCollection 2025.
3
Current Perspectives of Prenatal Cell-free DNA Screening in Clinical Management of First-Trimester Septated Cystic Hygroma.
孕早期分隔性囊状水囊瘤临床管理中产前游离DNA筛查的现状
Int J Womens Health. 2022 Oct 25;14:1499-1518. doi: 10.2147/IJWH.S328201. eCollection 2022.
4
First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.孕早期单独进行超声检查或与孕早期血清检查联合用于唐氏综合征筛查。
Cochrane Database Syst Rev. 2017 Mar 15;3(3):CD012600. doi: 10.1002/14651858.CD012600.